Chirality and drugs;Chiralite et medicament

Annales Pharmaceutiques Francaises

Volumn 58, Issue 4, 2000, Pages 239-246

  Testa, B ^a   Reist, M ^a   Carrupt, P A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Enantiomers; Epimerization; Eutomers; Metabolism; Racemization

Indexed keywords

CHLORAMPHETAMINE; CIMETIDINE; DEXTROMETHORPHAN; DRUG; OXAZEPAM; WARFARIN;

CHIRALITY; DRUG METABOLISM; DRUG STRUCTURE; ENANTIOMER; RACEMIC MIXTURE; REVIEW; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; ARTICLE; CHEMISTRY; DRUG THERAPY; PHARMACOKINETICS; STEREOISOMERISM;

DRUG THERAPY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; STEREOISOMERISM;

EID: 0033854245     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Cahn RC, Ingold C Prełog V. Specification of molecular chirality. Angew Chem Int Ed 1966; 5: 385-415.
2. Testa B. Principles of Organic Stereochemistry. New York: Dekker; 1979.
3. Testa B, Trager WF. Racemates versus enantiomers in drug development: dogmatism or pragmatism? Chirality 1990; 2 129-33.
4. Testa B. Mechanisms of chiral recognition in xenobiotic metabolism and drug-receptor interactions. Chirality 1989; 1: 7-9.
5. Testa B. Definitions and concepts in biochirality in Chirality and Biological Activity (Holmstedt B, Frank H, Testa B, Eds). New York: Liss; 1990, 15-32.
6. Barlow RB, Franks FM, Pearson JDM. The relation between biological activity and the degree of optical resolution of optical isomers. J Pharm Pharmacol 1972; 24: 753-61.
7. Testa B, Carrupt PA, Christiansen L, Christoffersen P, Reist M. Chirality in drug research: Stereomania, stereophobia, or stereophilia? in Trends in Receptor Research (Claassen V, Ed). Amsterdam: Elsevier; 1993, 1-8.
8. Testa B. Editorial - Stereophilia. Drug Metab Rev 1991; 24. 1-3.
9. Millership JS, Fitzpatrick A. Commonly used chiral drugs: A survey. Chirality 1993; 5 573-6.
10. Pfeiffer CC. Optical isomerism and pharmacological action, a generalization Science 1956; 124. 29-31.
11. Lehmann PA, Rodrigues de Miranda JF, Ariens EJ. Stereoselectivity and affinity in molecular pharmacology. Progr Drug Res 1976; 20 101-42.
12. Lehmann PA. stereoisomerism and drug action. Trends Pharmacol Sci 1986; 7. 281-5
13. Trofast J, Osterberg K, Kallström BL, Waldeck B. Steric aspects of agonism and antagonism at β-adrenoceptors: synthesis of and pharmacological experiments with the enantiomers of formoterol and their diastereomers. Chirality 1991; 3: 443-50.
14. Kwon YW, Triggle DJ. Chiral aspects of drug action at ion channels: a commentary on the stereoselectivity of drug actions at voltage-gated ion channels with particular reference to verapamil actions at the calcium channel. Chirality 1991; 3. 393-404.
15. Conte-Camerino D, Mambrini M, De Luca A, Tricarico D, Bryant SH, Tortorella V et al. Enantiomers of clofibric acid analogs have opposite actions on rat skeletal muscle chloride channels. Eur J Physiol 1988; 413: 105-7.
16. De Luca A, Tricarico D, Wagner R, Bryant SH, Tortorella V. Conte-Camerino D. Opposite effects of enantiomers of clofibric acid derivative on rat skeletal muscle chloride conductance: antagonism studies and theoretical modeling of two different receptor site interactions, J Pharmacol Exp Ther 1992; 260: 364-8.
17. Trager WF, Testa B, Stereoselective drug disposition in Drug Metabolism and Disposition: Considerations in Clinical Pharmacology (Wilkinson GR, Rawlins MD, Eds). Lancaster: MTP Press; 1985; 35-61.
18. Walle T, Walle UK. Pharmacokinetic parameters obtained with racemates. Trends Pharmacol Sci 1986; 7. 155-8.
19. Ames MM, Frank SK. Stereochemical aspects of para-chloroamphetamine metabolism. Rabbit liver microsomal metabolism of RS-, R(-)- and S(+)-para-chloroamphetamine. Biochem Pharmacol 1982; 31: 5-9.
20. Cundy KC, Crooks PA, Godin CS. Remarkable substrate-inhibitor properties of nicotine enantiomers towards a guinea pig lung aromatic azaheterocycle N-methyltransferase. Biochem Biophys Res Commun 1985; 128: 312-6.
21. Cooper MJ. Anders MW. Metabolic and pharmacodynamic interactions of enantiomers of propoxyphene and methorphan. Life Sci 1974; 15: 1665-72.
22. Choonara LA, Cholerton S, Haynes BP, Breckenridge AM, Park BK. Stereoselective interaction between the R enantiomers of warfarm and cimetidine. Brit J Clin Pharmacol 1986; 21: 271-8.
23. Testa B, Carrupt PA, Gal J. The so-called "interconversion" of stereoisomeric drugs: an attempt at clarification. Chirality 1993; 5. 105-11.
24. Aso Y, Yoshioka S, Shibazaki T. Uchiyama M. The kinetics of the racemization of oxazepam in aqueous solution. Chem Pharm Bull 1988; 36. 1834-40.
25. Testa B. Some chemical and stereochemical aspects of diethylpropion metabolism in man. Acta Pharm Suec 1973; 10: 441-54.
26. Reist M, Christiansen LH, Christoffersen P, Carrupt PA, Testa B. Low configurational stability of amfepramone and cathinone: mechanism and kinetics of chiral inversion. Chirality 1995; 7: 469-73.
27. Reist M, Carrupt PA, Testa B, Lehmann S, Hansen JJ. Kinetics and mechanisms of racemization: 5-substituted hvdantoins ( = imidazoline-2,4-diones) as models of chiral drugs. Heiv Chim Acta 1996; 79 767-78.
28. Nunes MA, Brochmann-Hanssen E. Hydrolysis and epimerization kinetics of pilocarpine in aqueous solution. J Pharm Sci 1974; 63. 716-21.